AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 61 filers reported holding AVROBIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $558,000 | -9.0% | 44,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $613,000 | -4.8% | 44,000 | -11.1% | 0.00% | -50.0% |
| Q3 2020 | $644,000 | -2.1% | 49,500 | +31.3% | 0.00% | 0.0% |
| Q2 2020 | $658,000 | +8.8% | 37,700 | -3.1% | 0.00% | 0.0% |
| Q1 2020 | $605,000 | +27.4% | 38,900 | +64.8% | 0.00% | +100.0% |
| Q4 2019 | $475,000 | +42.6% | 23,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $333,000 | +10.6% | 23,600 | +27.6% | 0.00% | 0.0% |
| Q2 2019 | $301,000 | -8.0% | 18,500 | +193.7% | 0.00% | 0.0% |
| Q3 2018 | $327,000 | – | 6,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 4,001,627 | $6,162,506 | 5.66% |
| Vazirani Asset Management LLC | 468,273 | $721,140 | 1.10% |
| Atlas Venture Life Science Advisors, LLC | 4,541,381 | $6,993,727 | 1.08% |
| Terrapin Asset Management, LLC | 558,787 | $860,532 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 3,512,686 | $5,409,536 | 0.76% |
| Newtyn Management, LLC | 2,000,000 | $3,080,000 | 0.76% |
| Aldebaran Capital, LLC | 470,130 | $724,000 | 0.74% |
| Aisling Capital Management LP | 1,009,779 | $1,555,060 | 0.64% |
| Western Standard LLC | 310,361 | $477,956 | 0.43% |
| Affinity Asset Advisors, LLC | 500,000 | $770,000 | 0.22% |